JAN

JanOne Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.09
+0.08
+1.60%
Closed 16:00 08/12 EDT
OPEN
5.10
PREV CLOSE
5.01
HIGH
5.16
LOW
4.480
VOLUME
221.20K
TURNOVER
--
52 WEEK HIGH
9.24
52 WEEK LOW
2.000
MARKET CAP
10.30M
P/E (TTM)
-0.7231
1D
5D
1M
3M
1Y
5Y

EPS

JAN News

More
UPDATE: JanOne's JAN101 Planned For Use To Treat Coronavirus Vascular Complications Pending Approval Of IND Submission, Expected To Be Completed In Late August
Benzinga · 1d ago
JanOne Completes Stable Formulation Of JAN101 In Preparation For Its First GMP Manufacturing Batch To Support Upcoming Clinical Trials
Benzinga · 1d ago
JanOne Engages CATO SMS, a World-Leading CRO, to Assist in the Development of JAN101 to Treat COVID-19 Vascular Complications
JanOne Inc. (Nasdaq: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, has entered into an agreement with CATO SMS, a world-leading, international regulatory
PR Newswire · 6d ago
JanOne Changes Internal Drug Candidate Name from TV1001SR to JAN101
JanOne Inc. (Nasdaq: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, announces a internal name change for its current drug candidate from TV1001SR to JAN101
PR Newswire · 08/04 13:47
JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional pain
JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with non-addictive pain-relieving properties has added two members to its impressive scientific advisory board. J
PR Newswire · 07/30 13:30
FDA authorizes for transfer of JanOne' IND application for its Sodium Nitrite tablets
Seeking Alpha - Article · 07/21 15:00
JanOne Receives FDA Authorization for Transfer of Investigational New Drug (IND) Application for its Sodium Nitrite Tablets
JanOne Inc. (NASDAQ: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain-relieving properties, has received confirmation from the Federal Food and Drug Administration (FDA) for the in
PR Newswire · 07/21 13:25
Dr. Rakesh Patel, internationally recognized scientist in nitric oxide and redox biology, and Dr. Timothy Ness, a pain mechanisms and medication expert, join JanOne's Scientific Advisory Board
PR Newswire · 07/08 14:30

Industry

Home Furnishings Retailers
+1.64%
Specialty Retailers
+1.94%

Hot Stocks

Symbol
Price
%Change

About JAN

JanOne Inc., formerly Appliance Recycling Centers of America, Inc., is engaged in the business of selling and recycling household appliances in North America. The Company has two segments: recycling and retail. It sells household appliances in the United States though its chain of Company-owned retail stores, operating under the name ApplianceSmart. Its recycling segment focuses on collecting, recycling and installing appliances for utilities and other customers. Its recycling segment focuses on the agreement with General Electric (GE). Its retail segment focuses on the sale of appliances through ApplianceSmart stores. It is a household appliance retailer with product categories, including commonly available appliances, and offerings, such as close-outs, factory overruns, discontinued models and special-buy appliances, including out-of-carton merchandise and others. It offers extended warranties, factory-trained technician service and recycling of customers' replaced appliances.
More

Webull offers kinds of Janone Inc stock information, including NASDAQ:JAN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading JAN stock methods without spending real money on the virtual paper trading platform.